Multiple sclerosis: Rebound syndrome after stopping fingolimod (Gilenya▼) or switching therapy

Access to the full content of this site is available only to registered healthcare professionals. Register to read more
Recently published articles have described rebound syndrome characterised by clinical and radiological signs of severe exacerbation in patients with multiple sclerosis after stopping treatment with Fingolimod (Gilenya▼) and in patients who were switched to other treatments.

Healthcare professionals are advised to report details of suspected adver...